Tumor website：www.tumorsci.org E-mail Alert
Evaluation of clinical efficacy and prognosis of luspatercept in the treatment of myelodysplastic syndrome based on red blood cell distribution width and Cyr61
LIU Gengrong, LI Wenbin, LI Guihu
Tumor . 2025, (03): 276 -286 .  DOI: 10.3781/j.issn.1000-7431.2025.2408-0476

Copyright © Tumor, All Rights Reserved.
E-mail: tumor@tumorsci.org
Powered by Beijing Magtech Co., Ltd.